134
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019

ORCID Icon, , ORCID Icon, , , , & ORCID Icon show all
Pages 1033-1046 | Received 26 Oct 2023, Accepted 25 Mar 2024, Published online: 14 May 2024

Figures & data

Table 1 Selected Characteristics by COPD Status Among Adults Aged ≥18 Years and in People Living with COPD Stratified by Race, 2016–2019 (MEPS)a

Table 2 Key Concurrent Conditions by COPD Status Among Adults Aged ≥18 Years and in People Living with COPD Stratified by Race, 2016–2019 (MEPS)a

Figure 1 Key cardiovascular concurrent conditionsa by COPD status among adults aged ≥18 years.

Notes: a Cardiovascular conditions included coronary heart disease, congestive heart failure, hypertension, dyslipidemia, and other heart disease. bAll differences were statistically significant (P<0.0001).
Abbreviation: COPD, chronic obstructive pulmonary disease.
Figure 1 Key cardiovascular concurrent conditionsa by COPD status among adults aged ≥18 years.

Figure 2 Socioeconomic and HRQoL outcomes in people living with COPD and without COPD, 2019 (MEPS).

Note: a All differences were statistically significant (P<0.0001).
Abbreviations: COPD, chronic obstructive pulmonary disease; MEPS, Medical Expenditures Survey; HRQoL, health-related quality of life.
Figure 2 Socioeconomic and HRQoL outcomes in people living with COPD and without COPD, 2019 (MEPS).

Figure 3 Socioeconomic and HRQoL outcomes in people living with COPD stratified by race, 2019 (MEPS).

Notes: aThis refers to those who were not employed/unemployed at the time of the MEPS interview. b P<0.0001. c P<0.001. d P<0.05.
Abbreviations: COPD – chronic obstructive pulmonary disease; MEPS – Medical Expenditures Survey; HRQoL – health-related quality of life.
Figure 3 Socioeconomic and HRQoL outcomes in people living with COPD stratified by race, 2019 (MEPS).

Table 3 Healthcare and Prescription Expenses by COPD Status and in People Living with COPD Stratified by Race, 2016–2019 (MEPS)

Figure 4 HCRU outcomes in people living with COPD and without COPD, 2019 (MEPS).

Note: a All differences were statistically significant (P<0.0001).
Abbreviations: COPD, chronic obstructive pulmonary disease; ED, emergency department; HCRU, healthcare resource utilization; MEPS, Medical Expenditures Survey.
Figure 4 HCRU outcomes in people living with COPD and without COPD, 2019 (MEPS).

Figure 5 HCRU outcomes in people living with COPD stratified by race, 2019 (MEPS).

Notes: aP<0.0001. bP=0.0172.
Abbreviations: COPD, chronic obstructive pulmonary disease; ED, emergency department; HCRU, healthcare resource utilization; MEPS, Medical Expenditures Survey.
Figure 5 HCRU outcomes in people living with COPD stratified by race, 2019 (MEPS).